Ilsa T. Kirby

5.9k total citations
13 papers, 504 citations indexed

About

Ilsa T. Kirby is a scholar working on Oncology, Electrical and Electronic Engineering and Immunology. According to data from OpenAlex, Ilsa T. Kirby has authored 13 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Electrical and Electronic Engineering and 4 papers in Immunology. Recurrent topics in Ilsa T. Kirby's work include PARP inhibition in cancer therapy (10 papers), Integrated Circuits and Semiconductor Failure Analysis (6 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Ilsa T. Kirby is often cited by papers focused on PARP inhibition in cancer therapy (10 papers), Integrated Circuits and Semiconductor Failure Analysis (6 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Ilsa T. Kirby collaborates with scholars based in United States, Canada and United Kingdom. Ilsa T. Kirby's co-authors include Michael S. Cohen, Andreja Mikoč, Petra Mikolčević, Edward Bartlett, Deeksha Munnur, J.G.M. Rack, Ivan Ahel, Diane E. Griffin, Age Utt and Anthony K. L. Leung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Molecular Biology.

In The Last Decade

Ilsa T. Kirby

13 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilsa T. Kirby United States 9 311 214 142 122 78 13 504
Robert Lyle McPherson United States 9 257 0.8× 165 0.8× 172 1.2× 144 1.2× 121 1.6× 12 492
Sarah Krieg Germany 9 274 0.9× 188 0.9× 127 0.9× 61 0.5× 90 1.2× 9 434
Mareike Bütepage Germany 11 408 1.3× 257 1.2× 204 1.4× 72 0.6× 149 1.9× 11 591
M. Schuller United Kingdom 12 248 0.8× 219 1.0× 101 0.7× 53 0.4× 70 0.9× 20 408
Hanife Bahsi Germany 9 84 0.3× 199 0.9× 42 0.3× 60 0.5× 8 0.1× 9 543
Valentine V. Courouble United States 7 42 0.1× 92 0.4× 43 0.3× 143 1.2× 17 0.2× 9 281
M.D. Rackham United Kingdom 7 92 0.3× 320 1.5× 22 0.2× 33 0.3× 11 0.1× 7 517
Rina Fong United States 7 118 0.4× 426 2.0× 93 0.7× 112 0.9× 7 0.1× 8 649
Rachna Aneja United States 11 32 0.1× 199 0.9× 38 0.3× 110 0.9× 4 0.1× 16 436
Reshu Saxena India 9 58 0.2× 186 0.9× 35 0.2× 48 0.4× 3 0.0× 16 395

Countries citing papers authored by Ilsa T. Kirby

Since Specialization
Citations

This map shows the geographic impact of Ilsa T. Kirby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilsa T. Kirby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilsa T. Kirby more than expected).

Fields of papers citing papers by Ilsa T. Kirby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilsa T. Kirby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilsa T. Kirby. The network helps show where Ilsa T. Kirby may publish in the future.

Co-authorship network of co-authors of Ilsa T. Kirby

This figure shows the co-authorship network connecting the top 25 collaborators of Ilsa T. Kirby. A scholar is included among the top collaborators of Ilsa T. Kirby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilsa T. Kirby. Ilsa T. Kirby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Langelier, Marie-France, Ilsa T. Kirby, Daniel S. Bejan, et al.. (2022). Allosteric regulation of DNA binding and target residence time drive the cytotoxicity of phthalazinone-based PARP-1 inhibitors. Cell chemical biology. 29(12). 1694–1708.e10. 7 indexed citations
2.
Bejan, Daniel S., Sunil K. Sundalam, Haihong Jin, et al.. (2022). Structure-guided design and characterization of a clickable, covalent PARP16 inhibitor. Chemical Science. 13(46). 13898–13906. 9 indexed citations
3.
Kirby, Ilsa T., et al.. (2021). PASTA: PARP activity screening and inhibitor testing assay. STAR Protocols. 2(1). 100344–100344. 7 indexed citations
4.
Buch-Larsen, Sara C., Ilsa T. Kirby, David Hutin, et al.. (2021). Chemical genetics and proteome-wide site mapping reveal cysteine MARylation by PARP-7 on immune-relevant protein targets. eLife. 10. 63 indexed citations
5.
Kirby, Ilsa T., et al.. (2021). Rational design of selective inhibitors of PARP4. RSC Medicinal Chemistry. 12(11). 1950–1957. 7 indexed citations
6.
Munnur, Deeksha, Edward Bartlett, Petra Mikolčević, et al.. (2019). Reversible ADP-ribosylation of RNA. Nucleic Acids Research. 47(11). 5658–5669. 122 indexed citations
7.
Abraham, Rachy, Debra Hauer, Robert Lyle McPherson, et al.. (2018). ADP-ribosyl–binding and hydrolase activities of the alphavirus nsP3 macrodomain are critical for initiation of virus replication. Proceedings of the National Academy of Sciences. 115(44). E10457–E10466. 97 indexed citations
8.
Kirby, Ilsa T., A.G. Thorsell, T. Karlberg, et al.. (2018). A Potent and Selective PARP11 Inhibitor Suggests Coupling between Cellular Localization and Catalytic Activity. Cell chemical biology. 25(12). 1547–1553.e12. 53 indexed citations
9.
Kirby, Ilsa T. & Michael S. Cohen. (2018). Small-Molecule Inhibitors of PARPs: From Tools for Investigating ADP-Ribosylation to Therapeutics. Current topics in microbiology and immunology. 420. 211–231. 25 indexed citations
10.
Morgan, Rory K., et al.. (2018). Rational Design of Cell-Active Inhibitors of PARP10. ACS Medicinal Chemistry Letters. 10(1). 74–79. 26 indexed citations
11.
Kirby, Ilsa T., Rory K. Morgan, & Michael S. Cohen. (2018). A Simple, Sensitive, and Generalizable Plate Assay for Screening PARP Inhibitors. Methods in molecular biology. 1813. 245–252. 3 indexed citations
12.
Pryke, Kara, Jinu Abraham, Tina M. Sali, et al.. (2017). A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. mBio. 8(3). 31 indexed citations
13.
Stammers, D.K., D.O. Somers, Carl Ross, et al.. (1994). Crystals of HIV-1 Reverse Transcriptase Diffracting to 2·2 Å Resolution. Journal of Molecular Biology. 242(4). 586–588. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026